rs267607084
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_025137.4(SPG11):c.118C>T(p.Gln40Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000691 in 1,446,226 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_025137.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPG11 | NM_025137.4 | c.118C>T | p.Gln40Ter | stop_gained | 1/40 | ENST00000261866.12 | NP_079413.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPG11 | ENST00000261866.12 | c.118C>T | p.Gln40Ter | stop_gained | 1/40 | 1 | NM_025137.4 | ENSP00000261866 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000475 AC: 1AN: 210306Hom.: 0 AF XY: 0.00000860 AC XY: 1AN XY: 116288
GnomAD4 exome AF: 6.91e-7 AC: 1AN: 1446226Hom.: 0 Cov.: 32 AF XY: 0.00000139 AC XY: 1AN XY: 718334
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hereditary spastic paraplegia 11 Pathogenic:2Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 10, 2015 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 10, 2023 | ClinVar contains an entry for this variant (Variation ID: 1111). This premature translational stop signal has been observed in individuals with hereditary spastic paraplegia and/or juvenile amyotrophic lateral sclerosis (PMID: 17322883, 20110243). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs267607084, gnomAD 0.004%). This sequence change creates a premature translational stop signal (p.Gln40*) in the SPG11 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SPG11 are known to be pathogenic (PMID: 19105190, 20110243, 22154821, 26556829). For these reasons, this variant has been classified as Pathogenic. - |
Amyotrophic lateral sclerosis type 5 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 10, 2015 | - - |
Charcot-Marie-Tooth disease axonal type 2X Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 10, 2015 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at